Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.475 USD | +3.15% | +1.72% | -19.84% |
May. 21 | Biodesix, Inc. to Present New Data on the Nodify XL2 Test at ATS 2024 Annual Meeting | CI |
May. 13 | TD Cowen Starts Biodesix With Buy Rating, $2.80 Price Target | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
BIODESIX, INC. | Medical & Diagnostic Laboratories | +3.08% | +1.72% | -19.84% | +4.61% | - | 208M |
- Stock Market
- Equities
- BDSX Stock
- Charts Biodesix, Inc.
- Relative Strength Chart